Skip to main content

JIA-like in a boy with Ataxia-telangiectasia

Introduction

Mechanisms of autoimmunity in primary immunodeficiencies (PID) are, in many situations, unclear. Despite being linked with many PIDs (namely humoral), juvenile idiopathic arthritis (JIA) has rarely been associated with DNA-repair disorders, such as Ataxia-telangiectasia (A-T).

Objectives

We report a case of JIA-like in a male patient with A-T.

Methods

A 3 year-old boy with A-T presented with pain and swelling of fourth metatarsophalangeal (MTP) joint of left foot. Six months later, this symptom persists and arthritis of the left knee was noted, so he was referred to rheumatology consult.

Results

At first evaluation he had arthritis of both knees, left ankle and 4th MTF of the left foot and tenosynovitis of second finger of the right hand. His immune evaluation revealed an important CD4 naif lymphopenia, abnormal proliferative responses to mitogens, skewed Vbeta repertoire and expanded gammadelta T cells, as well as conserved humoral response. Laboratory investigations showed erythrocyte sedimentation rate 25 mm/hr, C- reactive protein 14.5 mg/l, antinuclear antibodies positive (1/80), anti-cyclic citrullinated protein antibodies and rheumatoid factor were negative. A JIA-like disease was assumed, he started ibuprofen (30 mg/kg/day), and a chemical synovectomy with triamcinolone hexacetonide (TH) was performed (knees and ankle).

Ten months after diagnosis, knees and left ankle remain without active synovitis, but active 4th MTP of left foot and tenosynovitis of 2nd finger of right hand persists despite moderate improvement. Taking in account the underlying immune defect methotrexate was not an option and hydroxichloroquine (5 mg/kg/day) was started.

Conclusion

This case seems to be the first known pediatric patient with A-T who developed chronic, JIA-like disease. The management of these patients is particularly difficult because they are extremely susceptible to DNA damage and show an unusual susceptibility to viral infections (namely herpetic). These features are very important when considering the best therapeutic options for JIA-like disease.

Disclosure of interest

None declared.

Author information

Authors and Affiliations

Authors

Rights and permissions

Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.

The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Furtado, F., Cordeiro, A.I., Neves, J. et al. JIA-like in a boy with Ataxia-telangiectasia. Pediatr Rheumatol 12 (Suppl 1), P212 (2014). https://doi.org/10.1186/1546-0096-12-S1-P212

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/1546-0096-12-S1-P212

Keywords

  • Ibuprofen
  • Juvenile Idiopathic Arthritis
  • Synovitis
  • Lymphopenia
  • Left Knee